@contravir.com
Hepion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of targeted therapies for liver disease.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
Hepion Pharmaceuticals is a clinical stage biopharmaceutical company that specializes in Artificial Intelligence (AI)-driven therapeutic drug development. They focus on finding effective treatments for chronic liver diseases such as non-alcoholic steatohepatitis (NASH), fibrotic diseases, hepatocellular carcinoma (HCC), and other chronic diseases. Their lead drug candidate, rencofilstat, is a powerful inhibitor of cyclophilins, which play a crucial role in various disease processes.
Rencofilstat has demonstrated promising results in reducing liver fibrosis and hepatocellular carcinoma tumor burden in experimental disease models. Currently, it is in Phase 2 clinical development for the treatment of NASH. Hepion Pharmaceuticals utilizes AI-POWRβ’, a unique combination of Artificial Intelligence, Machine Learning, and Deep Learning, to decode diseases, develop targeted therapies, and identify patients who are likely to respond well to their treatments.
With a mission to tackle chronic liver disease, Hepion Pharmaceuticals strives to provide a broad spectrum liver therapy that can benefit the millions of individuals worldwide who are at risk without new therapeutic options
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories